Why Was Covishield Denied 'Green Pass' by European Medicine Agency Republic World - 30 Apr 2024 Why Was Covishield Denied 'Green Pass' by European Medicine Agency ... More
EMA awards double validation for Daiichi Sankyo and AstraZeneca’s cancer ADC Pharmaceutical Technology - 04 Mar 2024 EMA awards double validation for Daiichi Sankyo and AstraZeneca’s cancer ADC ... More
EMA Validates Parallel Applications for Datopotamab Deruxtecan in Two Types of Cancer Pharmaceutical Technology Magazine - 08 Mar 2024 EMA Validates Parallel Applications for Datopotamab Deruxtecan in Two Types of Cancer ... More
AstraZeneca and Daiichi Sankyo's Dato-DXd validated by EMA for lung and breast cancer treatment DirectorsTalk Interviews - 04 Mar 2024 AstraZeneca and Daiichi Sankyo's Dato-DXd validated by EMA for lung and breast cancer treatment ... More
Viewpoint: EU pharma reform will stifle innovation, says AstraZeneca's Stefan Woxström Science Business - 26 Oct 2023 Viewpoint: EU pharma reform will stifle innovation, says AstraZeneca's Stefan Woxström ... More
AstraZeneca's Danicopan Among Four Orphans Up For EU Approval Decision Pink Sheet - 19 Feb 2024 AstraZeneca's Danicopan Among Four Orphans Up For EU Approval Decision ... More
AstraZeneca Admits In Court Docs Covid Vaccine Can Cause RARE Side Effect, But What Does This Mean? MSN - 29 Apr 2024 AstraZeneca Admits In Court Docs Covid Vaccine Can Cause RARE Side Effect, But What Does This Mean? ... More
EMA validates Daiichi Sankyo-AstraZeneca's cancer therapy applications Pharmaceutical Business Review - 04 Mar 2024 EMA validates Daiichi Sankyo-AstraZeneca's cancer therapy applications ... More
EMA CHMP recommends AstraZeneca's Voydeya for PNH treatment Pharmaceutical Technology - 27 Feb 2024 EMA CHMP recommends AstraZeneca's Voydeya for PNH treatment ... More
Covid-19: EU states to resume AstraZeneca vaccine rollout BBC.com - 18 Mar 2021 Covid-19: EU states to resume AstraZeneca vaccine rollout ... More
AstraZeneca's Soliris given EU CHMP recommendation for marketing authorisation - PharmaTimes PharmaTimes - 26 Jun 2023 AstraZeneca's Soliris given EU CHMP recommendation for marketing authorisation - PharmaTimes ... More
EU regulator 'firmly convinced' that benefits of AstraZeneca vaccine outweigh the risks FRANCE 24 English - 16 Mar 2021 EU regulator 'firmly convinced' that benefits of AstraZeneca vaccine outweigh the risks ... More
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2022 ... European Medicines Agency | - 16 Dec 2022 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2022 ... ... More
EMA lists rare spinal condition as side effect of AstraZeneca's COVID-19 shot Reuters - 14 Jan 2022 EMA lists rare spinal condition as side effect of AstraZeneca's COVID-19 shot ... More
Which European states have paused AstraZeneca jabs due to clotting concerns? The Guardian - 15 Mar 2021 Which European states have paused AstraZeneca jabs due to clotting concerns? ... More
AstraZeneca vaccine: Europe divided over suspensions as investigation continues BBC.com - 16 Mar 2021 AstraZeneca vaccine: Europe divided over suspensions as investigation continues ... More
EMA CHMP issues positive opinion for AstraZeneca's Soliris Pharmaceutical Technology - 27 Jun 2023 EMA CHMP issues positive opinion for AstraZeneca's Soliris ... More
EMA dismisses thyroid cancer link with anti-obesity GLP-1 receptor agonists Pharmaceutical Technology - 30 Oct 2023 EMA dismisses thyroid cancer link with anti-obesity GLP-1 receptor agonists ... More
AstraZeneca jab: MHRA and EMA to give update on blood clot investigation The Guardian - 07 Apr 2021 AstraZeneca jab: MHRA and EMA to give update on blood clot investigation ... More